Thromb Haemost 1997; 77(05): 0986-0990
DOI: 10.1055/s-0038-1656090
Platelets
Schattauer GmbH Stuttgart

Deficiency of (33P)2MeS-ADP Binding Sites on Platelets with Secretion Defect, Normal Granule Stores and Normal Thromboxane A2 Production

Evidence that ADP Potentiates Platelet Secretion Independently of the Formation of Large Platelet Aggregates and Thromboxane A2 Production
Marco Cattaneo
1   The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, IRCCS Maggiore Hopsital, University of Milano, Italy;
,
Rossana Lombardi
1   The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, IRCCS Maggiore Hopsital, University of Milano, Italy;
,
Maddalena L Zighetti
1   The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, IRCCS Maggiore Hopsital, University of Milano, Italy;
,
Christian Gachet
2   INSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Etablissement de Transfusion Sanguine de Strasbourg, Strasbourg, France
,
Philippe Ohlmann
2   INSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Etablissement de Transfusion Sanguine de Strasbourg, Strasbourg, France
,
Jean-Pierre Cazenave
2   INSERM U.311, Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Etablissement de Transfusion Sanguine de Strasbourg, Strasbourg, France
,
Pier Mannuccio Mannucci
1   The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, IRCCS Maggiore Hopsital, University of Milano, Italy;
› Author Affiliations
Further Information

Publication History

Received 13 September 1996

Accepted after revision 23 January 1997

Publication Date:
11 July 2018 (online)

Summary

By the term “Primary Secretion Defect” (PSD), we mean a common heterogeneous group of congenital defects of platelet secretion, characterized by a normal primary wave of platelet aggregation induced by ADP and other agonists, a normal concentration of platelet granule contents, and normal production of thromboxane A2. The biochemical abnormalities responsible for PSD are not well known. Since a secretion defect similar to PSD is found in platelets that are severely deficient of binding sites for the ADP analogue 2MeS-ADP and do not aggregate in response to ADP, we tested the hypothesis that PSD platelets have moderately decreased 2MeS-ADP binding sites, which may be sufficient for normal ADP-induced aggregation but not for potentiating platelet secretion. The specific binding of [33P]2MeS-ADP to platelets from 3 PSD patients (347,443 and 490 sites/platelet; KD 2.8-3.9 nM) was lower than to platelets from 24 normal subjects (647 [530-1102]; KD = 3.8 [2.3-7.3]) (median [range]). Normal values were found in a fourth PSD patient (710; KD 3.7). The degree of inhibition of PGE1- induced cAMP increase by 0.1 |μM ADP was lower in patients than in controls. The secretion induced by the endoperoxide analogue U46619 from normal, acetylsalicylic acid-treated platelets under conditions that prevented the formation of large aggregates was potentiated by 1 fimol/1 ADP and inhibited by apyrase. These findings indicate that a partial deficiency of the platelet ADP receptor(s) might be responsible for the defect of platelet secretion in some PSD patients and that ADP potentiates platelet secretion independently of the formation of large aggregates and thromboxane A2 production.

 
  • References

  • 1 Rao AK. Congenital disorders of platelet function. In: Platelets in Health and Disease. Colman RW, Rao AK. eds. Hematol/Oncol Clin North Am. 1990. 04. 65-82
  • 2 Bennett JS. Hereditary disorders of platelet function. In: Hematology. Basic Principles and Practice. Hoffman R, Benz EJ Jr, Shattil SS, Furie B, Cohen HJ, Silberstein LE. eds. Churchill Livingstone; New York, NY: 1995. pp 1909-1925
  • 3 Weiss HJ, Witte LD, Kaplan KL, Lages BA, Chernoff A, Nossel HL, Goodman De WS, Baumgartner HR. Heterogeneity in storage pool deficiency: Studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979; 54: 1296-1319
  • 4 Lages B, Weiss HJ. Heterogeneous defects of platelet secretion and responses to weak agonists in patients with bleeding disorders. Br J Haematol 1988; 68: 53-62
  • 5 Rao AK, Kowalska MA, Disa J. Impaired cytoplasmic ionized calcium mobilization in inherited platelet secretion defects. Blood 1989; 74: 664-672
  • 6 Hardisty RM, Machin SJ, Nokes TJC, Rink TJ, Smith SW. A new congenital defect of platelet secretion: Impaired responsiveness of the platelets to cytoplasmic free calcium. Br J Haematol 1983; 53: 543-557
  • 7 Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-2796
  • 8 Gachet C, Cattaneo M, Ohlmann P, hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci PM, Cazenave J-P. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995; 91: 434-444
  • 9 Mills DCB, Puri R, Hu C-J, Minniti C, Grana G, Freedman MD, Colman RF, Colman RW. Clopidogrel inhibits the binding of ADP analogues to receptor mediating inhibition of platelet adenylate cyclase. Arterioscl Thromb 1992; 12: 430-436
  • 10 Cattaneo M, Akkawat B, Lecchi A, Cimminiello C, Capitanio AM, Mannucci PM. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate. Thromb Haemost 1991; 66: 694-699
  • 11 Nurden P, Savi P, Heilmann E, Bihour C, Herbert J-M, Maffrand J-P, Nurden A. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein Ilb-IIIa complex function. J Clin Invest 1995; 95: 1612-1622
  • 12 Wu KK, Le Breton GC, Tai H-H, Chen Y-C. Abnormal platelet responses to thromboxane A2 . J Clin Invest 1981; 67: 1801-1804
  • 13 Lages B, Malmsetn C, Weiss HJ. Samuelsson B: Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder. Blood 1981; 57: 545-552
  • 14 Hirata T, Kakizuka A, Ushikubi F, Fuse I, Okuma M, Narumiya S. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 1994; 94: 1662-1667
  • 15 Molnar J, Lorand L. Studies on apyrases. Arch Biochem Biophys 1960; 93: 353-363
  • 16 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1987; 22: 193-204
  • 17 Dangelmaier CA, Holmsen H. Platelet dense granule and lysosome content. In: Methods in Hematology. Measurement of Platelet Function. Harker LA, Zimmerman TS. eds. Edinburgh; Scotland: Churchill Livingstone: 1983. pp 92-114
  • 18 Drummond AH, Gordon J. Rapid sensitive microassay for platelet5HT. Thrombos Diathes Haemorrh (Stuttg) 1974; 31: 366-367
  • 19 Nakane PK, Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Hystochem Cytochem 1974; 22: 1084-1091
  • 20 Cattaneo M, Bettega D, Lombardi R, Lecchi A, Mannucci PM. Sustained correction of the bleeding time in an afibrinogenemic patient after infusion of fresh frozen plasma. Br J Haematol 1992; 82: 388-390
  • 21 Munson PJ, Rodbard D. Ligand: A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980; 107: 220-239
  • 22 Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-672
  • 23 Mei Huang E, Detwiler TC. Stimulus-response coupling mechanisms. In: Biochemistry of Platelets. Phillips DR, Shuman MA. eds. Orlando; FL: Academic Press Inc: 1986. pp 01-68
  • 24 Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 1975; 228: 1757-65